Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to polysaccharide-modified birch pollen in healthy adults
jRCTs031210524Recruiting
- Sponsor
- Wako Filter Technology
- Start
- Dec 2021
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial in normal comparing Polysaccharide-modified birch pollen with Placebo (2 arms). Primary endpoints: Serum birch-specific IgE, Serum birch-specific IgG and 6 more. Started Dec 2021; status: recruiting.
02
Drugs
polysaccharide-modified birch pollen
03
Conditions
normal
Beyond the preview
Go deeper on jRCTs031210524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210524.